These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 32557940)
1. Chromosomal instability upregulates interferon in acute myeloid leukemia. Jin N; Lera RF; Yan RE; Guo F; Oxendine K; Horner VL; Hu Y; Wan J; Mattison RJ; Weaver BA; Burkard ME Genes Chromosomes Cancer; 2020 Nov; 59(11):627-638. PubMed ID: 32557940 [TBL] [Abstract][Full Text] [Related]
2. Mitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology which Impacts Clinical Utility. Martinez R; Blasina A; Hallin JF; Hu W; Rymer I; Fan J; Hoffman RL; Murphy S; Marx M; Yanochko G; Trajkovic D; Dinh D; Timofeevski S; Zhu Z; Sun P; Lappin PB; Murray BW PLoS One; 2015; 10(9):e0138616. PubMed ID: 26398286 [TBL] [Abstract][Full Text] [Related]
3. Stable aneuploid tumors cells are more sensitive to TTK inhibition than chromosomally unstable cell lines. Libouban MAA; de Roos JADM; Uitdehaag JCM; Willemsen-Seegers N; Mainardi S; Dylus J; de Man J; Tops B; Meijerink JPP; Storchová Z; Buijsman RC; Medema RH; Zaman GJR Oncotarget; 2017 Jun; 8(24):38309-38325. PubMed ID: 28415765 [TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of pancreatic ductal adenocarcinoma cell growth by the mitotic MPS1 kinase inhibitor NMS-P715. Slee RB; Grimes BR; Bansal R; Gore J; Blackburn C; Brown L; Gasaway R; Jeong J; Victorino J; March KL; Colombo R; Herbert BS; Korc M Mol Cancer Ther; 2014 Feb; 13(2):307-315. PubMed ID: 24282275 [TBL] [Abstract][Full Text] [Related]
5. TC Mps1 12, a novel Mps1 inhibitor, suppresses the growth of hepatocellular carcinoma cells via the accumulation of chromosomal instability. Choi M; Min YH; Pyo J; Lee CW; Jang CY; Kim JE Br J Pharmacol; 2017 Jun; 174(12):1810-1825. PubMed ID: 28299790 [TBL] [Abstract][Full Text] [Related]
6. MPS1-dependent mitotic BLM phosphorylation is important for chromosome stability. Leng M; Chan DW; Luo H; Zhu C; Qin J; Wang Y Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11485-90. PubMed ID: 16864798 [TBL] [Abstract][Full Text] [Related]
7. Chemical genetic inhibition of Mps1 in stable human cell lines reveals novel aspects of Mps1 function in mitosis. Sliedrecht T; Zhang C; Shokat KM; Kops GJ PLoS One; 2010 Apr; 5(4):e10251. PubMed ID: 20422024 [TBL] [Abstract][Full Text] [Related]
8. Quantifying chromosomal instability from intratumoral karyotype diversity using agent-based modeling and Bayesian inference. Lynch AR; Arp NL; Zhou AS; Weaver BA; Burkard ME Elife; 2022 Apr; 11():. PubMed ID: 35380536 [TBL] [Abstract][Full Text] [Related]
9. DNA-damage response during mitosis induces whole-chromosome missegregation. Bakhoum SF; Kabeche L; Murnane JP; Zaki BI; Compton DA Cancer Discov; 2014 Nov; 4(11):1281-9. PubMed ID: 25107667 [TBL] [Abstract][Full Text] [Related]
10. Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. Janssen A; Kops GJ; Medema RH Proc Natl Acad Sci U S A; 2009 Nov; 106(45):19108-13. PubMed ID: 19855003 [TBL] [Abstract][Full Text] [Related]
11. Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis. Li JJ; Li SA Pharmacol Ther; 2006 Sep; 111(3):974-84. PubMed ID: 16603252 [TBL] [Abstract][Full Text] [Related]
12. High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers. Anderhub SJ; Mak GW; Gurden MD; Faisal A; Drosopoulos K; Walsh K; Woodward HL; Innocenti P; Westwood IM; Naud S; Hayes A; Theofani E; Filosto S; Saville H; Burke R; van Montfort RLM; Raynaud FI; Blagg J; Hoelder S; Eccles SA; Linardopoulos S Mol Cancer Ther; 2019 Oct; 18(10):1696-1707. PubMed ID: 31575759 [TBL] [Abstract][Full Text] [Related]
13. Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy. Faisal A; Mak GWY; Gurden MD; Xavier CPR; Anderhub SJ; Innocenti P; Westwood IM; Naud S; Hayes A; Box G; Valenti MR; De Haven Brandon AK; O'Fee L; Schmitt J; Woodward HL; Burke R; vanMontfort RLM; Blagg J; Raynaud FI; Eccles SA; Hoelder S; Linardopoulos S Br J Cancer; 2017 Apr; 116(9):1166-1176. PubMed ID: 28334731 [TBL] [Abstract][Full Text] [Related]
14. A Biosensor for the Mitotic Kinase MPS1 Reveals Spatiotemporal Activity Dynamics and Regulation. Kuijt TEF; Lambers MLA; Weterings S; Ponsioen B; Bolhaqueiro ACF; Staijen DHM; Kops GJPL Curr Biol; 2020 Oct; 30(19):3862-3870.e6. PubMed ID: 32888483 [TBL] [Abstract][Full Text] [Related]
15. Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro. Schenk EL; Koh BD; Flatten KS; Peterson KL; Parry D; Hess AD; Smith BD; Karp JE; Karnitz LM; Kaufmann SH Clin Cancer Res; 2012 Oct; 18(19):5364-73. PubMed ID: 22869869 [TBL] [Abstract][Full Text] [Related]
17. Monopolar spindle 1 (MPS1) kinase promotes production of closed MAD2 (C-MAD2) conformer and assembly of the mitotic checkpoint complex. Tipton AR; Ji W; Sturt-Gillespie B; Bekier ME; Wang K; Taylor WR; Liu ST J Biol Chem; 2013 Dec; 288(49):35149-58. PubMed ID: 24151075 [TBL] [Abstract][Full Text] [Related]
18. Mps1 inhibitors synergise with low doses of taxanes in promoting tumour cell death by enhancement of errors in cell division. Maia ARR; Linder S; Song JY; Vaarting C; Boon U; Pritchard CEJ; Velds A; Huijbers IJ; van Tellingen O; Jonkers J; Medema RH Br J Cancer; 2018 Jun; 118(12):1586-1595. PubMed ID: 29736010 [TBL] [Abstract][Full Text] [Related]
20. A small-molecule inhibitor of Mps1 blocks the spindle-checkpoint response to a lack of tension on mitotic chromosomes. Dorer RK; Zhong S; Tallarico JA; Wong WH; Mitchison TJ; Murray AW Curr Biol; 2005 Jun; 15(11):1070-6. PubMed ID: 15936280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]